Related Experiment Video
Updated: Jul 14, 2026
06:00
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
IL-7 modulates osteoclastogenesis in patients affected by solid tumors.
Ilaria Roato1, Eva Gorassini, Giacomina Brunetti
1Center for Experimental Research and Medical Studies, University and A.S.O. San Giovanni Battista, Turin, Italy. roato78@libero.it
Annals of the New York Academy of Sciences
|June 23, 2007
Summary
High interleukin-7 (IL-7) levels in osteolytic patients promote spontaneous bone loss by stimulating osteoclast formation. IL-7 may serve as a clinical marker for disease progression and bone metastases.
Area of Science:
- Immunology
- Oncology
- Bone Biology
Background:
- Elevated interleukin-7 (IL-7) levels are linked to bone loss via osteoclastogenic activity.
- Osteolytic patients exhibit spontaneous differentiation of peripheral blood mononuclear cells (PBMCs) into osteoclasts.
- The precise role of IL-7 in this spontaneous osteoclastogenesis requires further investigation.
Purpose of the Study:
- To investigate the role of IL-7 in spontaneous osteoclastogenesis in osteolytic patients.
- To assess the potential of IL-7 as a clinical marker for bone metastases and disease progression.
- To elucidate the mechanisms by which IL-7 influences osteoclast formation in this context.
Main Methods:
- Serum IL-7 levels were measured in patients with and without bone metastases.
- PBMC cultures from osteolytic patients were analyzed for osteoclast differentiation.
- The induction of TNF-alpha by IL-7 in T and B cells was assessed in PBMC cultures.
Main Results:
- Significant differences in serum IL-7 levels were observed between patients with and without bone metastases.
- IL-7 was demonstrated to stimulate osteoclastogenesis in patient-derived PBMC cultures.
- IL-7 induced the release of TNF-alpha by T and B cells within these cultures.
Conclusions:
- IL-7 plays a significant role in the spontaneous osteoclastogenesis observed in osteolytic patients.
- Serum IL-7 levels may serve as a valuable clinical biomarker for monitoring disease progression and bone metastases.
- IL-7-induced TNF-alpha production by lymphocytes contributes to the bone-resorbing mechanisms in solid tumors.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...